Login Register Cart 0
Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
Review Article

The Functional Role of Long Non-coding RNA UCA1 in Human Multiple Cancers: a Review Study

Author(s): Nashmin Fayazi Hosseini, Hamed Manoochehri, Saeideh Gholamzadeh Khoei and Mohsen Sheykhhasan*

Volume 21, Issue 2, 2021

Published on: 19 June, 2020

Page: [96 - 110] Pages: 15

DOI: 10.2174/1566524020666200619124543

Price: $65

Abstract

In various cancers, high-grade tumor and poor survival rate in patients with upregulated lncRNAs UCA1 have been confirmed. Urothelial carcinoma associated 1 (UCA1) is an oncogenic non-coding RNA with a length of more than 200 nucleotides. The UCA1 regulate critical biological processes that are involved in cancer progression, including cancer cell growth, invasion, migration, metastasis, and angiogenesis. So It should not surprise that UCA1 overexpresses in variety of cancers type, including pancreatic cancer, ovarian cancer, gastric cancer, colorectal cancer, breast cancer, prostate cancer, endometrial cancer, cervical cancer, bladder cancer, adrenal cancer, hypopharyngeal cancer, oral cancer, gallbladder cancer, nasopharyngeal cancer, laryngeal cancer, osteosarcoma, esophageal squamous cell carcinoma, renal cell carcinoma, cholangiocarcinoma, leukemia, glioma, thyroid cancer, medulloblastoma, hepatocellular carcinoma and multiple myeloma. In this article, we review the biological function and regulatory mechanism of UCA1 in several cancers and also, we will discuss the potential of its as cancer biomarker and cancer treatment.

Keywords: Long non-coding RNA, UCA1, cancer, regulatory mechanism, biomarker, therapy.

« Previous Next »
[1]
Nagai H, Kim YH. Cancer prevention from the perspective of global cancer burden patterns. J Thorac Dis 2017; 9(3): 448-51.
[http://dx.doi.org/10.21037/jtd.2017.02.75] [PMID: 28449441]
[2]
Lin L, Yan L, Liu Y, Yuan F, Li H, Ni J. Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study. J Hematol Oncol 2019; 12(1): 96.
[http://dx.doi.org/10.1186/s13045-019-0783-9] [PMID: 31511035]
[3]
Baselga J, Bhardwaj N, Cantley LC, et al. AACR Cancer Progress Report 2015. Clin Cancer Res 2015; 21(19)(Suppl.): S1-S128.
[http://dx.doi.org/10.1158/1078-0432.CCR-15-1846] [PMID: 26429991]
[4]
Liang X, Qi M, Wu R, et al. Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways. Int J Oncol 2018; 53(6): 2671-82.
[http://dx.doi.org/10.3892/ijo.2018.4574] [PMID: 30272271]
[5]
Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics 2013; 193(3): 651-69.
[http://dx.doi.org/10.1534/genetics.112.146704] [PMID: 23463798]
[6]
Carninci P, Kasukawa T, Katayama S, et al. FANTOM Consortium. RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group). The transcriptional landscape of the mammalian genome. Science 2005; 309(5740): 1559-63.
[http://dx.doi.org/10.1126/science.1112014] [PMID: 16141072]
[7]
Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature 2012; 489(7414): 101-8.
[http://dx.doi.org/10.1038/nature11233] [PMID: 22955620]
[8]
Bergmann JH, Spector DL. Long non-coding RNAs: modulators of nuclear structure and function. Curr Opin Cell Biol 2014; 26: 10-8.
[http://dx.doi.org/10.1016/j.ceb.2013.08.005] [PMID: 24529241]
[9]
Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012; 81: 145-66.
[http://dx.doi.org/10.1146/annurev-biochem-051410-092902] [PMID: 22663078]
[10]
Zuo Z-K, Gong Y, Chen X-H, et al. TGFβ1-induced lncRNA UCA1 upregulation promotes gastric cancer invasion and migration. DNA Cell Biol 2017; 36(2): 159-67.
[http://dx.doi.org/10.1089/dna.2016.3553] [PMID: 28075173]
[11]
Rackham O, Shearwood A-MJ, Mercer TR, Davies SM, Mattick JS, Filipovska A. Long noncoding RNAs are generated from the mitochondrial genome and regulated by nuclear-encoded proteins. RNA 2011; 17(12): 2085-93.
[http://dx.doi.org/10.1261/rna.029405.111] [PMID: 22028365]
[12]
Simon MD. Insight into lncRNA biology using hybridization capture analyses. Biochim Biophys Acta 2016; 1859(1): 121-7.
[http://dx.doi.org/10.1016/j.bbagrm.2015.09.004] [PMID: 26381323]
[13]
Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 2016; 17(1): 47-62.
[http://dx.doi.org/10.1038/nrg.2015.10] [PMID: 26666209]
[14]
Dahariya S, Paddibhatla I, Kumar S, Raghuwanshi S, Pallepati A, Gutti RK. Long non-coding RNA: Classification, biogenesis and functions in blood cells. Mol Immunol 2019; 112: 82-92.
[http://dx.doi.org/10.1016/j.molimm.2019.04.011] [PMID: 31079005]
[15]
Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature 2012; 482(7385): 339-46.
[http://dx.doi.org/10.1038/nature10887] [PMID: 22337053]
[16]
Chen L, Zhang Y-H, Pan X, et al. Tissue Expression Difference between mRNAs and lncRNAs. Int J Mol Sci 2018; 19(11): 3416.
[http://dx.doi.org/10.3390/ijms19113416] [PMID: 30384456]
[17]
Ni B, Yu X, Guo X, et al. Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer. Int J Oncol 2015; 47(4): 1329-38.
[http://dx.doi.org/10.3892/ijo.2015.3109] [PMID: 26238511]
[18]
Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell 2011; 43(6): 904-14.
[http://dx.doi.org/10.1016/j.molcel.2011.08.018] [PMID: 21925379]
[19]
Wang T, Yuan J, Feng N, et al. Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer. Tumour Biol 2014; 35(10): 10075-84.
[http://dx.doi.org/10.1007/s13277-014-2321-2] [PMID: 25015192]
[20]
Chen X, Sun Y, Cai R, Wang G, Shu X, Pang W. Long noncoding RNA: multiple players in gene expression. BMB Rep 2018; 51(6): 280-9.
[http://dx.doi.org/10.5483/BMBRep.2018.51.6.025] [PMID: 29636120]
[21]
Akkipeddi SMK, Velleca AJ, Carone DM. Probing the function of long noncoding RNAs in the nucleus. Chromosom Res 2020; pp. 1-24.
[22]
Wallace JG, Zhou Z, Breaker RR. OLE RNA protects extremophilic bacteria from alcohol toxicity. Nucleic Acids Res 2012; 40(14): 6898-907.
[http://dx.doi.org/10.1093/nar/gks352] [PMID: 22561371]
[23]
Ma L, Li A, Zou D, et al. LncRNAWiki: harnessing community knowledge in collaborative curation of human long non-coding RNAs. Nucleic Acids Res 2015; 43(Database issue): D187-92.
[http://dx.doi.org/10.1093/nar/gku1167] [PMID: 25399417]
[24]
Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov 2011; 1(5): 391-407.
[http://dx.doi.org/10.1158/2159-8290.CD-11-0209] [PMID: 22096659]
[25]
Liu C, Jin J, Shi J, et al. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis. Biosci Rep 2019; 39(4)BSR20180995
[http://dx.doi.org/10.1042/BSR20180995] [PMID: 30918102]
[26]
Xing Z, Park PK, Lin C, Yang L. LncRNA BCAR4 wires up signaling transduction in breast cancer. RNA Biol 2015; 12(7): 681-9.
[http://dx.doi.org/10.1080/15476286.2015.1053687] [PMID: 26016563]
[27]
Enfield KS, Pikor LA, Martinez VD, Lam WL. Mechanistic roles of noncoding RNAs in lung cancer biology and their clinical implications Genet Res Int 2012 2012..
[http://dx.doi.org/10.1155/2012/737416]
[28]
Kang K, Huang Y-H, Li H-P, Guo S-M. Expression of UCA1 and MALAT1 long-chain non-coding RNAs in esophageal squamous cell carcinoma tissues is predictive of patient prognosis. Arch Med Sci 2018; 14(4): 752-9.
[http://dx.doi.org/10.5114/aoms.2018.73713] [PMID: 30002691]
[29]
Huang D, Chen J, Yang L, et al. NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death. Nat Immunol 2018; 19(10): 1112-25.
[http://dx.doi.org/10.1038/s41590-018-0207-y] [PMID: 30224822]
[30]
Liu Q, Huang J, Zhou N, et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res 2013; 41(9): 4976-87.
[http://dx.doi.org/10.1093/nar/gkt182] [PMID: 23558749]
[31]
Liu X, Li D, Zhang W, Guo M, Zhan Q. Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay. EMBO J 2012; 31(23): 4415-27.
[http://dx.doi.org/10.1038/emboj.2012.292] [PMID: 23103768]
[32]
Paralkar VR, Weiss MJ. A new ‘Linc’ between noncoding RNAs and blood development. Genes Dev 2011; 25(24): 2555-8.
[http://dx.doi.org/10.1101/gad.183020.111] [PMID: 22190456]
[33]
Matouk I, Raveh E, Ohana P, et al. The increasing complexity of the oncofetal h19 gene locus: functional dissection and therapeutic intervention. Int J Mol Sci 2013; 14(2): 4298-316.
[http://dx.doi.org/10.3390/ijms14024298] [PMID: 23429271]
[34]
Tang H, Wu Z, Zhang J, Su B. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep 2013; 7(3): 761-6.
[http://dx.doi.org/10.3892/mmr.2012.1254] [PMID: 23292713]
[35]
Lorenzen JM, Schauerte C, Kölling M, et al. Long Noncoding RNAs in Urine Are Detectable and May Enable Early Detection of Acute T Cell-Mediated Rejection of Renal Allografts. Clin Chem 2015; 61(12): 1505-14.
[http://dx.doi.org/10.1373/clinchem.2015.243600] [PMID: 26506996]
[36]
Wang F, Li X, Xie X, Zhao L, Chen W. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 2008; 582(13): 1919-27.
[http://dx.doi.org/10.1016/j.febslet.2008.05.012] [PMID: 18501714]
[37]
Wang X-S, Zhang Z, Wang H-C, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res 2006; 12(16): 4851-8.
[http://dx.doi.org/10.1158/1078-0432.CCR-06-0134] [PMID: 16914571]
[38]
Yang C, Li X, Wang Y, Zhao L, Chen W. Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene 2012; 496(1): 8-16.
[http://dx.doi.org/10.1016/j.gene.2012.01.012] [PMID: 22285928]
[39]
Han Y, Yang YN, Yuan HH, et al. UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology 2014; 46(5): 396-401.
[http://dx.doi.org/10.1097/PAT.0000000000000125] [PMID: 24977734]
[40]
Xuan W, Yu H, Zhang X, Song D. Crosstalk between the lncRNA UCA1 and microRNAs in cancer. FEBS Lett 2019; 593(15): 1901-14.
[http://dx.doi.org/10.1002/1873-3468.13470] [PMID: 31166011]
[41]
Li Z, Yu D, Li H, Lv Y, Li S. Long non coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway. Int J Oncol 2019; 54(3): 1033-42.
[http://dx.doi.org/10.3892/ijo.2019.4679] [PMID: 30628639]
[42]
Wu W, Zhang S, Li X, Xue M, Cao S, Chen W. Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS One 2013; 8(9)e73920
[http://dx.doi.org/10.1371/journal.pone.0073920] [PMID: 24069250]
[43]
Jin B, Gong Y, Li H, et al. C/EBPβ promotes the viability of human bladder cancer cell by contributing to the transcription of bladder cancer specific lncRNA UCA1. Biochem Biophys Res Commun 2018; 506(3): 674-9.
[http://dx.doi.org/10.1016/j.bbrc.2018.10.152] [PMID: 30376994]
[44]
Cui M, Chen M, Shen Z, Wang R, Fang X, Song B. LncRNA-UCA1 modulates progression of colon cancer through regulating the miR-28-5p/HOXB3 axis. J Cell Biochem 2019; 120(5): 6926-36.
[http://dx.doi.org/10.1002/jcb.27630] [PMID: 30652355]
[45]
Lee J-J, Kim M, Kim H-P. Epigenetic regulation of long noncoding RNA UCA1 by SATB1 in breast cancer. BMB Rep 2016; 49(10): 578-83.
[http://dx.doi.org/10.5483/BMBRep.2016.49.10.156] [PMID: 27697109]
[46]
Jin K-T, Yao J-Y, Fang X-L, Di H, Ma Y-Y. Roles of lncRNAs in cancer: Focusing on angiogenesis. Life Sci 2020.252117647
[http://dx.doi.org/10.1016/j.lfs.2020.117647] [PMID: 32275935]
[47]
Wang H, Guan Z, He K, Qian J, Cao J, Teng L. LncRNA UCA1 in anti-cancer drug resistance. Oncotarget 2017; 8(38): 64638-50.
[http://dx.doi.org/10.18632/oncotarget.18344] [PMID: 28969100]
[48]
Xiao C, Wu CH, Hu HZ. LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway. Eur Rev Med Pharmacol Sci 2016; 20(13): 2819-24.
[PMID: 27424981]
[49]
Luo J, Chen J, Li H, et al. LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway. Oncol Lett 2017; 14(5): 5556-62.
[http://dx.doi.org/10.3892/ol.2017.6886] [PMID: 29113184]
[50]
de Groot RP, Ballou LM, Sassone-Corsi P. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternative route to mitogen-induced gene expression. Cell 1994; 79(1): 81-91.
[http://dx.doi.org/10.1016/0092-8674(94)90402-2] [PMID: 7923380]
[51]
Ma H, Su R, Feng H, Guo Y, Su G. Long noncoding RNA UCA1 promotes osteosarcoma metastasis through CREB1-mediated epithelial-mesenchymal transition and activating PI3K/AKT/mTOR pathway. J Bone Oncol 2019.16100228
[http://dx.doi.org/10.1016/j.jbo.2019.100228] [PMID: 31011522]
[52]
Kong L, Wu Q, Zhao L, Ye J, Li N, Yang H. Upregulated lncRNA-UCA1 contributes to metastasis of bile duct carcinoma through regulation of miR-122/CLIC1 and activation of the ERK/MAPK signaling pathway. Cell Cycle 2019; 18(11): 1212-28.
[http://dx.doi.org/10.1080/15384101.2019.1593647] [PMID: 31106658]
[53]
Liu P, Zhu L, Zhang F, et al. LncRNA UCA1/miR-143 miR-216b/HK2/MAPK signaling pathway is involved in the regulation of endothelial cell proliferation via the modulation of glycolysis in melanoma. Eur J Inflamm 2019.172058739219837050
[54]
Li JL, Liu XL, Guo SF, Yang Y, Zhu YL, Li JZ. Long noncoding RNA UCA1 regulates proliferation and apoptosis in multiple myeloma by targeting miR-331-3p/IL6R axis for the activation of JAK2/STAT3 pathway. Eur Rev Med Pharmacol Sci 2019; 23(21): 9238-50.
[PMID: 31773675]
[55]
Chen X, Gao J, Yu Y, Zhao Z, Pan Y. Long non-coding RNA UCA1 targets miR-185-5p and regulates cell mobility by affecting epithelial-mesenchymal transition in melanoma via Wnt/β-catenin signaling pathway. Gene 2018; 676: 298-305.
[http://dx.doi.org/10.1016/j.gene.2018.08.065] [PMID: 30144501]
[56]
He Z, Wang Y, Huang G, Wang Q, Zhao D, Chen L. The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting iASPP. Arch Biochem Biophys 2017; 623-624: 1-8.
[http://dx.doi.org/10.1016/j.abb.2017.01.013] [PMID: 28137422]
[57]
Wang C-J, Zhu C-C, Xu J, et al. The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs. Mol Cancer 2019; 18(1): 115.
[http://dx.doi.org/10.1186/s12943-019-1032-0] [PMID: 31272462]
[58]
Wang P, Liu X, Han G, et al. Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression. Cell Cycle 2019; 18(18): 2359-76.
[http://dx.doi.org/10.1080/15384101.2019.1648959] [PMID: 31387451]
[59]
Yu Y, Gao F, He Q, Li G, Ding G. LncRNA UCA1 functions as a ceRNA to promote prostate cancer progression via Sponging miR143. Mol Ther Nucleic Acids 2020; 19: 751-8.
[http://dx.doi.org/10.1016/j.omtn.2019.11.021] [PMID: 31954329]
[60]
Luan Y, Li X, Luan Y, et al. Circulating lncRNA UCA1 promotes malignancy of colorectal cancer via the miR-143/MYO6 axis. Mol Ther Nucleic Acids 2020; 19: 790-803.
[http://dx.doi.org/10.1016/j.omtn.2019.12.009] [PMID: 31955010]
[61]
He C, Lu X, Yang F, et al. LncRNA UCA1 acts as a sponge of miR-204 to up-regulate CXCR4 expression and promote prostate cancer progression. Biosci Rep 2019; 39(5)BSR20181465
[http://dx.doi.org/10.1042/BSR20181465] [PMID: 30940776]
[62]
Bian Z, Jin L, Zhang J, et al. LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep 2016; 6: 23892.
[http://dx.doi.org/10.1038/srep23892] [PMID: 27046651]
[63]
Gong P, Qiao F, Wu H, et al. LncRNA UCA1 promotes tumor metastasis by inducing miR-203/ZEB2 axis in gastric cancer. Cell Death Dis 2018; 9(12): 1158.
[http://dx.doi.org/10.1038/s41419-018-1170-0] [PMID: 30464170]
[64]
Jin Y, Chen Z, Liu X, Zhou X. Evaluating the microRNA targeting sites by luciferase reporter gene assay MicroRNA Protocols. Springer 2013; pp. 117-27.
[65]
Wu H, Zhou C. Long non-coding RNA UCA1 promotes lung cancer cell proliferation and migration via microRNA-193a/HMGB1 axis. Biochem Biophys Res Commun 2018; 496(2): 738-45.
[http://dx.doi.org/10.1016/j.bbrc.2018.01.097] [PMID: 29355524]
[66]
Zhu HY, Bai WD, Ye XM, Yang AG, Jia LT. Long non-coding RNA UCA1 desensitizes breast cancer cells to trastuzumab by impeding miR-18a repression of Yes-associated protein 1. Biochem Biophys Res Commun 2018; 496(4): 1308-13.
[http://dx.doi.org/10.1016/j.bbrc.2018.02.006] [PMID: 29408336]
[67]
Jiao C, Song Z, Chen J, et al. lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer. Oncol Rep 2016; 36(5): 2960-6.
[http://dx.doi.org/10.3892/or.2016.5121] [PMID: 27667646]
[68]
Wang F, Ying H-Q, He B-S, et al. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 2015; 6(10): 7899-917.
[http://dx.doi.org/10.18632/oncotarget.3219] [PMID: 25760077]
[69]
Xiao Y, Jiao C, Lin Y, et al. lncRNA UCA1 contributes to imatinib resistance by acting as a ceRNA against miR-16 in chronic myeloid leukemia cells. DNA Cell Biol 2017; 36(1): 18-25.
[http://dx.doi.org/10.1089/dna.2016.3533] [PMID: 27854515]
[70]
Cao C, Zhang J, Yang C, Xiang L, Liu W. Silencing of long noncoding RNA UCA1 inhibits colon cancer invasion, migration and epithelial-mesenchymal transition and tumour formation by upregulating miR-185-5p in vitro and in vivo. Cell Biochem Funct 2020; 38(2): 176-84.
[http://dx.doi.org/10.1002/cbf.3454] [PMID: 31989667]
[71]
Yan Q, Tian Y, Hao F. Downregulation of lncRNA UCA1 inhibits proliferation and invasion of cervical cancer cells through miR-206 expression. Oncol Res 2018.
[http://dx.doi.org/10.3727/096504018X15185714083446] [PMID: 29523226]
[72]
Yin D, Fu C, Sun D. Silence of lncRNA UCA1 Represses the Growth and Tube Formation of Human Microvascular Endothelial Cells Through miR-195. Cell Physiol Biochem 2018; 49(4): 1499-511.
[http://dx.doi.org/10.1159/000493454] [PMID: 30205377]
[73]
Shi T, Gao G. Cao YJDm.Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics. In:Dis Markers vol. 2016; p. 908519510..
[74]
Arriaga-Canon C, De La Rosa-Velázquez IA, González-Barrios R, et al. The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer. Oncotarget 2018; 9(29): 20872-90.
[http://dx.doi.org/10.18632/oncotarget.25038] [PMID: 29755696]
[75]
Shan L, Liu C, Ma C. High Expression of Serum UCA1 may be a Potential Biomarker for Clinical Diagnosis of Gastric Cancer. Clin Lab 2019; 65(9)
[http://dx.doi.org/10.7754/Clin.Lab.2019.190317] [PMID: 31532112]
[76]
Pan J, Xie X, Li H, Li Z, Ren C, Ming L. Detection of serum long non-coding RNA UCA1 and circular RNAs for the diagnosis of bladder cancer and prediction of recurrence. Int J Clin Exp Pathol 2019; 12(8): 2951-8.
[PMID: 31934131]
[77]
Liu J, Guo B. RNA-based therapeutics for colorectal cancer: Updates and future directions. Pharmacol Res 2020.152104550
[http://dx.doi.org/10.1016/j.phrs.2019.104550] [PMID: 31866285]
[78]
Lennox KA, Behlke MA. Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides. Nucleic Acids Res 2016; 44(2): 863-77.
[http://dx.doi.org/10.1093/nar/gkv1206] [PMID: 26578588]
[79]
Jiang M-C, Ni J-J, Cui W-Y, Wang B-Y, Zhuo W. Emerging roles of lncRNA in cancer and therapeutic opportunities. Am J Cancer Res 2019; 9(7): 1354-66.
[PMID: 31392074]
[80]
Fu X, Liu Y, Zhuang C, Liu L, Cai Z, Huang W. Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637. Mol Biosyst 2015; 11(5): 1285-9.
[http://dx.doi.org/10.1039/C5MB00127G] [PMID: 25800227]
[81]
Hong S, Yan Z, Song Y, Bi M, Li S. LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer. Aging (Albany NY) 2020; 12(6): 5183-94.
[http://dx.doi.org/10.18632/aging.102940] [PMID: 32202509]
[82]
Wang X, Yang B, Ma B. The UCA1/miR-204/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells. Cancer Chemother Pharmacol 2016; 78(5): 1025-31.
[http://dx.doi.org/10.1007/s00280-016-3158-8] [PMID: 27686228]
[83]
Ho T-T, Zhou N, Huang J, Koirala P, Xu M, Fung R, et al. Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines. Nucleic Acids Res 2015; 43(3): e17-e...
[84]
Liu D, Du L, Chen D, et al. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling. Oncotarget 2016; 7(26): 40704-18.
[http://dx.doi.org/10.18632/oncotarget.9930] [PMID: 27302922]
[85]
Yao F, Wang Q, Wu Q. The prognostic value and mechanisms of lncRNA UCA1 in human cancer. Cancer Manag Res 2019; 11: 7685-96.
[http://dx.doi.org/10.2147/CMAR.S200436] [PMID: 31616184]
[86]
Qian Y, Liu D, Cao S, et al. Upregulation of the long noncoding RNA UCA1 affects the proliferation, invasion, and survival of hypopharyngeal carcinoma. Mol Cancer 2017; 16(1): 68.
[http://dx.doi.org/10.1186/s12943-017-0635-6] [PMID: 28327194]
[87]
Ramos MC, Boulaiz H, Griñan-Lison C, Marchal JA, et al. What’s new in treatment of pancreatic cancer: a patent review (2010–2017). Expert Opin Ther Pat 2017; 27(11): 1251-66.
[88]
Na X-Y, Liu Z-Y, Ren P-P, Yu R, Shang X-S. Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway. Int J Clin Exp Med 2015; 8(8): 12609-16.
[PMID: 26550172]
[89]
Ghafouri-Fard S, Taheri M. UCA1 long non-coding RNA: An update on its roles in malignant behavior of cancers. Biomed Pharmacother 2019.120109459
[http://dx.doi.org/10.1016/j.biopha.2019.109459] [PMID: 31585301]
[90]
Zhang S, Dong X, Ji T, Chen G, Shan L. Long non-coding RNA UCA1 promotes cell progression by acting as a competing endogenous RNA of ATF2 in prostate cancer. Am J Transl Res 2017; 9(2): 366-75.
[PMID: 28337266]
[91]
Zhang M, Zhao Y, Zhang Y, et al. LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway. Biochim Biophys Acta Mol Basis Dis 2018; 1864(5 Pt A): 1770-82.
[http://dx.doi.org/10.1016/j.bbadis.2018.03.005] [PMID: 29510195]
[92]
Ding W, Fan X-L, Xu X, et al. Epigenetic silencing of ITGA2 by MiR-373 promotes cell migration in breast cancer. PLoS One 2015; 10(8)e0135128
[http://dx.doi.org/10.1371/journal.pone.0135128] [PMID: 26258411]
[93]
Zhang X, Gao F, Zhou L, Wang H, Shi G, Tan X. UCA1 regulates the growth and metastasis of pancreatic cancer by sponging miR-135a. Oncol Res 2017; 25(9): 1529-41.
[http://dx.doi.org/10.3727/096504017X14888987683152] [PMID: 28315290]
[94]
Chung HH, Hwang SY, Jung KW, et al. Gynecologic Oncology Committee of Korean Society of Obstetrics and Gynecology. Ovarian cancer incidence and survival in Korea: 1993-2002. Int J Gynecol Cancer 2007; 17(3): 595-600.
[http://dx.doi.org/10.1111/j.1525-1438.2007.00824.x] [PMID: 17300678]
[95]
Wang F, Zhou J, Xie X, et al. Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cells. Neoplasma 2015; 62(3): 432-8.
[http://dx.doi.org/10.4149/neo_2015_051] [PMID: 25967360]
[96]
Yang Y, Jiang Y, Wan Y, et al. UCA1 functions as a competing endogenous RNA to suppress epithelial ovarian cancer metastasis. Tumour Biol 2016; 37(8): 10633-41.
[http://dx.doi.org/10.1007/s13277-016-4917-1] [PMID: 26867765]
[97]
Wang J, Ye C, Liu J, Hu Y. UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis. Biochem Biophys Res Commun 2018; 501(4): 1034-40.
[http://dx.doi.org/10.1016/j.bbrc.2018.05.104] [PMID: 29777711]
[98]
Lin X, Spindler TJ, de Souza Fonseca MA, et al. Super-Enhancer-Associated LncRNA UCA1 Interacts Directly with AMOT to Activate YAP Target Genes in Epithelial Ovarian Cancer. iScience 2019; 17: 242-255..
[99]
Horita K, Kurosaki H, Nakatake M, et al. lncRNA UCA1-Mediated Cdc42 Signaling Promotes Oncolytic Vaccinia Virus Cell-to-Cell Spread in Ovarian Cancer. Mol Ther Oncolytics 2019; 13: 35-48.
[http://dx.doi.org/10.1016/j.omto.2019.03.003] [PMID: 31011626]
[100]
Li Z, Niu H, Qin Q, et al. lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer. Mol Ther Nucleic Acids 2019; 17: 92-101.
[http://dx.doi.org/10.1016/j.omtn.2019.05.007] [PMID: 31234009]
[101]
Bian Y, Wang L, Lu H, et al. Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis. Biochem Biophys Res Commun 2012; 422(1): 187-93.
[http://dx.doi.org/10.1016/j.bbrc.2012.04.138] [PMID: 22569043]
[102]
Li T, Mo X, Fu L, Xiao B, Guo J. Molecular mechanisms of long noncoding RNAs on gastric cancer. Oncotarget 2016; 7(8): 8601-12.
[http://dx.doi.org/10.18632/oncotarget.6926] [PMID: 26788991]
[103]
Pang Q, Ge J, Shao Y, et al. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol 2014; 35(6): 5441-7.
[http://dx.doi.org/10.1007/s13277-014-1709-3] [PMID: 24523021]
[104]
He X, Wang J, Chen J, et al. lncRNA UCA1 Predicts a Poor Prognosis and Regulates Cell Proliferation and Migration by Repressing p21 and SPRY1 Expression in GC. Mol Ther Nucleic Acids 2019; 18: 605-16.
[http://dx.doi.org/10.1016/j.omtn.2019.09.024] [PMID: 31689615]
[105]
Pan J, Dai Q, Zhang T, Li C. Palmitate acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway. Cancer Cell Int 2019; 19(1): 69.
[http://dx.doi.org/10.1186/s12935-019-0787-0] [PMID: 30948929]
[106]
Sun L, Liu L, Yang J, Li H, Zhang C. SATB1 3′-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer. J Cell Biochem 2019; 120(4): 6671-82.
[http://dx.doi.org/10.1002/jcb.27963] [PMID: 30368875]
[107]
Qin L, Jia Z, Xie D, Liu Z. Knockdown of long noncoding RNA urothelial carcinoma-associated 1 inhibits cell viability, migration, and invasion by regulating microRNA-182 in gastric carcinoma. J Cell Biochem 2018; 119(12): 10075-86.
[http://dx.doi.org/10.1002/jcb.27344] [PMID: 30129054]
[108]
Yang Z, Shi X, Li C, et al. Long non-coding RNA UCA1 upregulation promotes the migration of hypoxia-resistant gastric cancer cells through the miR-7-5p/EGFR axis. Exp Cell Res 2018; 368(2): 194-201.
[http://dx.doi.org/10.1016/j.yexcr.2018.04.030] [PMID: 29723509]
[109]
Nasrollahzadeh-Khakiani M, Emadi-Baygi M, Nikpour P. Augmented expression levels of lncRNAs ecCEBPA and UCA1 in gastric cancer tissues and their clinical significance. Iran J Basic Med Sci 2017; 20(10): 1149-58.
[PMID: 29147491]
[110]
Li C, Liang G, Yang S, et al. Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway. Oncotarget 2017; 8(55): 93476-91.
[http://dx.doi.org/10.18632/oncotarget.19281] [PMID: 29212166]
[111]
Wang ZQ, He CY, Hu L, et al. Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer. Cancer Lett 2017; 408: 10-21.
[http://dx.doi.org/10.1016/j.canlet.2017.08.013] [PMID: 28843497]
[112]
Deng M, Zeng C, Lu X, et al. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop. Cancer Lett 2017; 403: 175-85.
[http://dx.doi.org/10.1016/j.canlet.2017.06.006] [PMID: 28634044]
[113]
Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin 2017; 67(3): 177-93.
[http://dx.doi.org/10.3322/caac.21395] [PMID: 28248415]
[114]
Eaton L. World cancer rates set to double by 2020. BMJ 2003; 326(7392): 728.
[http://dx.doi.org/10.1136/bmj.326.7392.728/a] [PMID: 12676827]
[115]
Siddiqui H, Al-Ghafari A, Choudhry H, Al Doghaither H. Roles of long non-coding RNAs in colorectal cancer tumorigenesis: A Review. Mol Clin Oncol 2019; 11(2): 167-72.
[http://dx.doi.org/10.3892/mco.2019.1872] [PMID: 31281651]
[116]
Zhao W, Ma X, Liu L, et al. SNHG20: A vital lncRNA in multiple human cancers. J Cell Physiol 2019; 234(9): 14519-25.
[http://dx.doi.org/10.1002/jcp.28143] [PMID: 30644099]
[117]
Horita K, Kurosaki H, Nakatake M, Ito M, Kono H, Nakamura T. Long noncoding RNA UCA1 enhances sensitivity to oncolytic vaccinia virus by sponging miR-18a/miR-182 and modulating the Cdc42/filopodia axis in colorectal cancer. Biochem Biophys Res Commun 2019; 516(3): 831-8.
[http://dx.doi.org/10.1016/j.bbrc.2019.06.125] [PMID: 31262449]
[118]
Yang YN, Zhang R, Du JW, et al. Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer. Cancer Cell Int 2018; 18(1): 164.
[http://dx.doi.org/10.1186/s12935-018-0660-6] [PMID: 30377411]
[119]
Wu F, Zhou D, Cui Y, Shen G, Li Y, Wei F. Long non-coding RNA UCA1 modulates the glycolysis of cervical cancer cells by miR-493-5p/HK2. Int J Clin Exp Pathol 2018; 11(8): 3943-51.
[PMID: 31949782]
[120]
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69(1): 7-34.
[http://dx.doi.org/10.3322/caac.21551] [PMID: 30620402]
[121]
Liu H, Wang G, Yang L, Qu J, Yang Z, Zhou X. Knockdown of long non-coding RNA UCA1 increases the tamoxifen sensitivity of breast cancer cells through inhibition of Wnt/β-catenin pathway. PLoS One 2016; 11(12)e0168406
[http://dx.doi.org/10.1371/journal.pone.0168406] [PMID: 27977766]
[122]
Tuo YL, Li XM, Luo J. Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143. Eur Rev Med Pharmacol Sci 2015; 19(18): 3403-11.
[PMID: 26439035]
[123]
Huang J, Zhou N, Watabe K, et al. Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis 2014; 5(1)e1008
[http://dx.doi.org/10.1038/cddis.2013.541] [PMID: 24457952]
[124]
Li W, Xie P, Ruan WH. Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis. J Bone Oncol 2016; 5(2): 80-5.
[http://dx.doi.org/10.1016/j.jbo.2016.05.003] [PMID: 27335776]
[125]
Li J-Y, Ma X, Zhang C-B. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 2014; 7(11): 7938-44.
[PMID: 25550835]
[126]
Li Y, Wang T, Li Y, et al. Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma. Mol Med Rep 2016; 13(4): 3326-34.
[http://dx.doi.org/10.3892/mmr.2016.4894] [PMID: 26935146]
[127]
Wu J, Du M, Zhang Q, et al. Long noncoding RNA UCA1 promotes the proliferation, invasion, and migration of nasopharyngeal carcinoma cells via modulation of miR-145. OncoTargets Ther 2018; 11: 7483-92.
[http://dx.doi.org/10.2147/OTT.S182290] [PMID: 30498361]
[128]
Sun S, Gong C, Yuan K. LncRNA UCA1 promotes cell proliferation, invasion and migration of laryngeal squamous cell carcinoma cells by activating Wnt/β-catenin signaling pathway. Exp Ther Med 2019; 17(2): 1182-9.
[PMID: 30679991]
[129]
Zhang TH, Liang LZ, Liu XL, et al. LncRNA UCA1/miR-124 axis modulates TGFβ1-induced epithelial-mesenchymal transition and invasion of tongue cancer cells through JAG1/Notch signaling. J Cell Biochem 2019; 120(6): 10495-504.
[http://dx.doi.org/10.1002/jcb.28334] [PMID: 30635938]
[130]
Cai Q, Jin L, Wang S, et al. Long non-coding RNA UCA1 promotes gallbladder cancer progression by epigenetically repressing p21 and E-cadherin expression. Oncotarget 2017; 8(29): 47957-68.
[http://dx.doi.org/10.18632/oncotarget.18204] [PMID: 28624787]
[131]
Xu Y, Yao Y, Leng K, et al. Long non-coding RNA UCA1 indicates an unfavorable prognosis and promotes tumorigenesis via regulating AKT/GSK-3β signaling pathway in cholangiocarcinoma. Oncotarget 2017; 8(56): 96203-14.
[http://dx.doi.org/10.18632/oncotarget.21884] [PMID: 29221199]
[132]
Zhou Y, Wang X, Zhang J, et al. Artesunate suppresses the viability and mobility of prostate cancer cells through UCA1, the sponge of miR-184. Oncotarget 2017; 8(11): 18260-70.
[http://dx.doi.org/10.18632/oncotarget.15353] [PMID: 28209917]
[133]
Lu L, Shen Y, Tseng K-F, Liu W, Duan H, Meng W. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell. Cancer Biomark 2016; 17(2): 171-7.
[http://dx.doi.org/10.3233/CBM-160628] [PMID: 27540975]
[134]
Yan Q, Tian Y, Hao F. Downregulation of lncRNA UCA1 inhibits proliferation and invasion of cervical cancer cells through miR-206 expression. Oncol 2019.
[135]
Cheng Y, Huang C, Mo Y, Wu W, Liang L. Long non-coding RNA UCA1 regulates tumor growth by impairing let-7e-dependent HMGA2 repression in bladder cancer. CANCER BIOMARK 2019; 1-11. [Preprint
[http://dx.doi.org/10.3233/CBM-182296]
[136]
Guo N, Sun Q, Fu D, Zhang Y. Long non-coding RNA UCA1 promoted the growth of adrenocortical cancer cells via modulating the miR-298-CDK6 axis. Gene 2019; 703: 26-34.
[http://dx.doi.org/10.1016/j.gene.2019.03.066] [PMID: 30935924]
[137]
Sun MD, Zheng YQ, Wang LP, Zhao HT, Yang S. Long noncoding RNA UCA1 promotes cell proliferation, migration and invasion of human leukemia cells via sponging miR-126. Eur Rev Med Pharmacol Sci 2018; 22(8): 2233-45.
[PMID: 29762824]
[138]
Xin H, Liu N, Xu X, et al. Knockdown of lncRNA-UCA1 inhibits cell viability and migration of human glioma cells by miR-193a-mediated downregulation of CDK6. J Cell Biochem 2019; 120(9): 15157-69.
[http://dx.doi.org/10.1002/jcb.28777] [PMID: 31111564]
[139]
Li D, Hao S, Zhang J. Long non-coding RNA UCA1 exerts growth modulation by miR-15a in human thyroid cancer TPC-1 cells. Artif Cells Nanomed Biotechnol 2019; 47(1): 1815-22.
[http://dx.doi.org/10.1080/21691401.2019.1606007] [PMID: 31062608]
[140]
Zhengyuan X, Hu X, Qiang W, Nanxiang L, Junbin C, Wangming Z. Silencing of urothelial carcinoma associated 1 inhibits the proliferation and migration of medulloblastoma cells. Med Sci Monit 2017; 23: 4454-61.
[http://dx.doi.org/10.12659/MSM.904675] [PMID: 28916736]
[141]
Zhao B, Lu Y, Cao X, et al. MiRNA-124 inhibits the proliferation, migration and invasion of cancer cell in hepatocellular carcinoma by downregulating lncRNA-UCA1. OncoTargets Ther 2019; 12: 4509-16.
[http://dx.doi.org/10.2147/OTT.S205169] [PMID: 31354286]
[142]
Zhang J, Zhang C. Silence of long non-coding RNA UCA1 inhibits hemangioma cells growth, migration and invasion by up-regulation of miR-200c. Life Sci 2019; 226: 33-46.
[http://dx.doi.org/10.1016/j.lfs.2019.03.038] [PMID: 30898646]
[143]
Yang Y, Chen L. Downregulation of lncRNA UCA1 facilitates apoptosis and reduces proliferation in multiple myeloma via regulation of the miR-1271-5p/HGF axis. J Chin Med Assoc 2019; 82(9): 699-709.
[http://dx.doi.org/10.1097/JCMA.0000000000000145] [PMID: 31356563]
[144]
Han R, Chen S, Wang J, Zhao Y, Li G. LncRNA UCA1 affects epithelial-mesenchymal transition, invasion, migration and apoptosis of nasopharyngeal carcinoma cells. Cell Cycle 2019; 18(21): 3044-53.
[http://dx.doi.org/10.1080/15384101.2019.1667707] [PMID: 31537148]
[145]
Wu C, Luo J. Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway. Med Sci Monit 2016; 22: 3860-7.
[http://dx.doi.org/10.12659/MSM.900689] [PMID: 27765938]
[146]
Li Y, Zeng Q, Qiu J, Pang T, Xian J, Zhang X. Long non-coding RNA UCA1 promotes breast cancer by upregulating PTP1B expression via inhibiting miR-206. Cancer Cell Int 2019; 19(1): 275.
[http://dx.doi.org/10.1186/s12935-019-0958-z] [PMID: 31695578]
[147]
Liu C, Ji L, Song X. Long non coding RNA UCA1 contributes to the autophagy and survival of colorectal cancer cells via sponging miR-185-5p to up-regulate the WISP2/β-catenin pathway. RSC Advances 2019; 9(25): 14160-6.
[http://dx.doi.org/10.1039/C8RA10468A]
[148]
Zhang L, Zheng C, Sun Z, Wang H, Wang F. Long non-coding RNA urothelial cancer associated 1 can regulate the migration and invasion of colorectal cancer cells (SW480) via myocardin-related transcription factor-A. Oncol Lett 2019; 18(4): 4185-93.
[http://dx.doi.org/10.3892/ol.2019.10737] [PMID: 31579420]
[149]
Cao Y, Xiong J-B, Zhang G-Y, Liu Y, Jie Z-G, Li Z-R. Long Noncoding RNA UCA1 Regulates PRL-3 Expression by Sponging MicroRNA-495 to Promote the Progression of Gastric Cancer. MOL THER-NUCL ACIDS 2019.
[150]
Gu L, Lu LS, Zhou DL, Liu ZC. UCA1 promotes cell proliferation and invasion of gastric cancer by targeting CREB1 sponging to miR-590-3p. Cancer Med 2018; 7(4): 1253-63.
[http://dx.doi.org/10.1002/cam4.1310] [PMID: 29516678]
[151]
Tao K, Yang J, Hu Y, et al. Clinical significance of urothelial carcinoma associated 1 in colon cancer. Int J Clin Exp Med 2015; 8(11): 21854-60.
[PMID: 26885155]
[152]
Tang R-X, Chen Z-M, Zeng J-J, Chen G, Luo D-Z, Mo W-J. Clinical implication of UCA1 in non-small cell lung cancer and its effect on caspase-3/7 activation and apoptosis induction in vitro. Int J Clin Exp Pathol 2018; 11(5): 2295-304.
[PMID: 31938341]
[153]
Li Q, Xing W, Gong X, Wang Y. Long Non-Coding RNA Urothelial Carcinoma Associated 1 Promotes Proliferation, Migration and Invasion of Osteosarcoma Cells by Regulating microRNA-182. Cell Physiol Biochem 2018; 51(3): 1149-63.
[http://dx.doi.org/10.1159/000495493] [PMID: 30481751]
[154]
Su Y, Zhou Y, Sun YJ, et al. Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1. J Mol Med (Berl) 2019; 97(1): 49-61.
[http://dx.doi.org/10.1007/s00109-018-1711-0] [PMID: 30426155]
[155]
Lu HW, Liu XD. UCA1 promotes papillary thyroid carcinoma development by stimulating cell proliferation via Wnt pathway. Eur Rev Med Pharmacol Sci 2018; 22(17): 5576-82.
[PMID: 30229831]
[156]
Liu Y, Feng W, Gu S, et al. The UCA1/KRAS axis promotes human pancreatic ductal adenocarcinoma stem cell properties and tumor growth. Am J Cancer Res 2019; 9(3): 496-510.
[PMID: 30949406]
[157]
Gong J, Lu X, Xu J, Xiong W, Zhang H, Yu X. Coexpression of UCA1 and ITGA2 in pancreatic cancer cells target the expression of miR-107 through focal adhesion pathway. J Cell Physiol 2019; 234(8): 12884-96.
[http://dx.doi.org/10.1002/jcp.27953] [PMID: 30569514]
[158]
Zhou Y, Chen Y, Ding W, et al. LncRNA UCA1 impacts cell proliferation, invasion, and migration of pancreatic cancer through regulating miR-96/FOXO3. IUBMB Life 2018; 70(4): 276-90.
[http://dx.doi.org/10.1002/iub.1699] [PMID: 29500870]
[159]
Zhou Y, Li Y, Wang N, Li X, Zheng J, Ge L. UPF1 inhibits the hepatocellular carcinoma progression by targeting long non-coding RNA UCA1. Sci Rep 2019; 9(1): 6652.
[http://dx.doi.org/10.1038/s41598-019-43148-z] [PMID: 31040354]
[160]
Zhang B, Fang S, Cheng Y, Zhou C, Deng F. The long non-coding RNA, urothelial carcinoma associated 1, promotes cell growth, invasion, migration, and chemo-resistance in glioma through Wnt/β-catenin signaling pathway. Aging (Albany NY) 2019; 11(19): 8239-53.
[http://dx.doi.org/10.18632/aging.102317] [PMID: 31596734]
[161]
Xue M, Pang H, Li X, Li H, Pan J, Chen W. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci 2016; 107(1): 18-27.
[http://dx.doi.org/10.1111/cas.12844] [PMID: 26544536]
[162]
Wu J, Li W, Ning J, Yu W, Rao T, Cheng F. Long noncoding RNA UCA1 targets miR-582-5p and contributes to the progression and drug resistance of bladder cancer cells through ATG7-mediated autophagy inhibition. OncoTargets Ther 2019; 12: 495-508.
[http://dx.doi.org/10.2147/OTT.S183940] [PMID: 30666128]
[163]
Han C, Tang F, Chen J, et al. Knockdown of lncRNA-UCA1 inhibits the proliferation and migration of melanoma cells through modulating the miR-28-5p/HOXB3 axis. Exp Ther Med 2019; 17(5): 4294-302.
[http://dx.doi.org/10.3892/etm.2019.7421] [PMID: 30988802]
[164]
Fang Z, Zhao J, Xie W, Sun Q, Wang H, Qiao B. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Cancer Med 2017; 6(12): 2897-908.
[http://dx.doi.org/10.1002/cam4.1253] [PMID: 29125238]
[165]
Li O, Yi W, Yang P, Guo C, Peng C. Long non-coding RNA UCA1 promotes proliferation and invasion of intrahepatic cholangiocarcinoma cells through targeting microRNA-122. Exp Ther Med 2019; 18(1): 25-32.
[http://dx.doi.org/10.3892/etm.2019.7564] [PMID: 31258634]
[166]
Liu C, Zhang H, Liu H. Long Noncoding RNA UCA1 Accelerates Nasopharyngeal Carcinoma Cell Progression By Modulating miR-124-3p/ITGB1 Axis. OncoTargets Ther 2019; 12: 8455-66.
[http://dx.doi.org/10.2147/OTT.S215819] [PMID: 31632090]

Rights & Permissions Print Cite
Article Metrics
42
1
© 2024 Bentham Science Publishers | Privacy Policy